Regulatory Hurdles for Novel Diagnostic Technologies
Published on: 22/06/2024
Discover the regulatory challenges facing novel diagnostic technologies, including liquid biopsy, AI-driven diagnostics, digital pathology, multiplex biomarkers, and evolving FDA regulatory frameworks.
The Diagnostic Edge

